RBC Life Sciences, Inc. (OTCQB: RBCL) announced today that the Company's stem cell supplement, Stem-Kine™, has been approved for importation and sale in Taiwan. Stem-Kine is marketed in Taiwan under the name SK Plus.
"Stem cells are early stage cells, formed primarily in bone marrow that can develop into any type of cell -- heart, brain, or other tissues. Stem cells circulate with the blood, congregating in diseased or damaged tissues, where they replace the injured cells with healthy new cells.
"Stem cells form the body's internal repair and rejuvenation system. Physicians consistently report that a greater number of the body's own adult stem cells results in more effective repair.
"Young people have higher levels of stem cells, and usually recover more quickly from injuries or illness. Beginning in our twenties, our stem cell levels begin a constant decline. However, we can increase our stem cell levels with exercise and healthy nutrition.
"Stem-Kine was developed as optimum nourishment to bone marrow, enabling it to produce more stem cells. In two published studies, Stem-Kine was shown to result in an increase of 50% to 100% in the subject's level of circulating stem cells over a prolonged period of time," stated Clinton Howard, CEO of RBC Life Sciences.
Scientists uncover a cell responsible for repairing damaged liver tissue